| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Aldrich Richard serves as a Director at KALV and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 25 buys and 0 sells. Those positions are worth an estimated $8.0M at current prices.
The biggest single holding is KALV (~$8.0M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 565,065 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 59,029 | $7.90 | $466,104.20 | +36.3% | |
| Mar 14, 2016 | TPST Tempest Therapeutics, Inc. | Director | Buy | 162,732 | $7.60 | $1,237,092.00 | New | |
| Apr 8, 2015 | TPST Tempest Therapeutics, Inc. | Director | Buy | 2,500 | $29.97 | $74,925.00 | +12.6% |